Sex differences and survival in latecomers with ST-elevationmyocardial infarction

Authors: Konovalova E.V., Luk'yanova Yu.V., Gorev M.V., Reztsov R.Yu., Makarycheva O.V., Vasilieva E.Yu., Shpektor A.V. 

Company: Cardiology Chair for Post-Diploma Education Faculty of Moscow State University of Medicine and Dentistry named after A.I. Evdokimov of Ministry of Health of the Russian Federation; Delegatskaya ulitsa, 20/1, Moscow, 127473, Russian Federation

For correspondence:  Sign in or register.


DOI: https://doi.org/10.15275/kreatkard.2016.04.03

For citation: Konovalova E.V., Luk'yanova Yu.V., Gorev M.V., Reztsov R.Yu., Makarycheva O.V., Vasilieva E.Yu., Shpektor A.V. Sex differences and survival in latecomers with ST-elevationmyocardial infarction. Creative Cardiology. 2016; 10 (4): 290-295 (in Russ.).

Keywords: revascularization acute coronary syndrome survival rates prognosis gender

Download
Full text:  

 

Abstract

Objective. The early outcomes after acute myocardial infarction (AMI) are better in men than in women. The aim of this study was to evaluate the gender differences in the long-term prognosis in patients with ST-elevation myocardial infarction (STEMI) hospitalized after 12 hours from symptoms onset.
Material and methods. The data of 178 patients (117 (66%) men), with STEMI hospitalized later than 12 hours after the onset of symptoms was retrospectively analyzed. The mean time from the symptoms onset to the admission was 96.6 hours. Percutaneous coronary intervention (PCI) was performed in 83 (47%) patients 59 (71.1%) men. Other 95 (53%) patients (58 (61.1%) men), were treated conservatively. The 3-year mortality was evaluated using Kaplan–Meier estimation.
Results. The 3-year mortality was higher in women than in men hospitalized later than 12 hours from symptoms onset (36% vs. 19.6, HR 0.54, 95% confidence interval (CI) 0.33–0.89, p=0.009). The long term mortality in women who underwent revascularization was 16% (4 pts), while in the conservative treatment group it was 48% (18 pts) (HR 0.29, 95% CI 0.11–0.77, p=0.001). Long term mortality in men who underwent PCI was (7 pts), in the conservative treatment group – 28% (16 pts) (HR 0.43, 95% CI 0.19–0.96, p=0.024). In the PCI group the long term survival did not differ in women and in men (HR 0.71; 95% CI 0.22–2.21, p=0.5).
Conclusion. Although the long-term prognosis is worse in women with STEMI hospitalized late after symptoms onset in comparison to men, PCI in women with STEMI admitted more than 12 hours after the onset of symptoms leads to improved long term prognosis.

References

  1. Moss A.J., Bigger J.T., Case R.B., Gillespie J.A., Goldstein R.E., Groenberg H.M. et al. Risk stratification and survival after myocardial infarction. N. Engl. J. Med. 1983; 309 (6): 331–6.
  2. Ho C.-H. Chen Y.-C., Chu C.C., Wang J.J., Liao K.M. Postoperative complications after coronary artery bypass grafting in patients with chronic obstructive pulmonary disease. Medicine (Baltimore). 2016; 95 (8): e2926.
  3. Eagle K.A., Nallamothu B.K., Mehta R.H., Granger C.B., Steg P.G., Van de Werf F. et al. Trends in acute reperfusion therapy for ST-segment elevation myocardial infarction from 1999 to 2006: we are getting better but we have got a long way to go. Eur. Heart J. 2008; 29 (5): 609–17.
  4. Yin W.-H., Lu T.H., Chen K.C., Cheng C.F., Lee J.C., Liang F.W. et al. The temporal trends of incidence, treatment, and in-hospital mortality of acute myocardial infarction over 15 years in a Taiwanese population. Int. J. Cardiol. 2016; 209: 103–13.
  5. Critchley J.A., Capewell S. Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review. JAMA. 2003; 290 (1): 86–97.
  6. Tverdal A., Bjartveit K. Health consequences of reduced daily cigarette consumption. Tob. Control. 2006; 15 (6): 472–80.
  7. Yeh R.W., Sidney S., Chandra M., Sorel M., Selby J.V., Go A.S. Population trends in the incidence and outcomes of acute myocardial infarction. N. Engl. J. Med. 2010; 362 (23): 2155–65.
  8. Mehta L.S., Beckie T.M., DeVon H.A., Grines C.L., Krumholz H.M., Johnson M.N. et al. Acute myocardial infarction in women: a scientific statement from the American Heart Association. Circulation. 2016; 133 (9): 916–47.
  9. Elosua R., Vega G., Rohlfs I., Aldasoro E., Navarro C., Cabades A. et al. Smoking and myocardial infarction case-fatality: hospital and population approach. Eur. J. Cardiovasc. Prev. Rehabil. 2007; 14 (4): 561–7.
  10. Nedkoff L., Knuiman M., Hung J., Briffa T.G. Long-term all-cause and cardiovascular mortality following incident myocardial infarction in men and women with and without diabetes: Temporal trends from 1998 to 2009. Eur. J. Prev. Cardiol. 2016; 23 (12): 1273–81.
  11. Berkowitz S.D., Granger C.B., Pieper K.S., Lee K.L., Gore J.M., Simoons M. et al. Incidence and predictors of bleeding after contemporary thrombolytic therapy for myocardial infarction. The Global Utilization of Streptokinase and Tissue Plasminogen activator for Occluded coronary arteries (GUSTO) I Investigators. Circulation. 1997; 95 (11): 2508–16.
  12. Weiss E.S., Chang D.D., Joyce D.L., Nwakanma L.U., Yuh D.D. et al. Optimal timing of coronary artery bypass after acute myocardial infarction: a review of California discharge data. J. Thorac. Cardiovasc. Surg. 2008; 135 (3): 503–11.
  13. Weaver W.D., White H.D., Wilcox R.G., Aylward P.E., Morris D., Guerci A. et al. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators. JAMA. 1996; 275 (10): 777–82.
  14. Stefanini G.G., Baber U., Windecker S., Morice M.C., Sartori S., Leon M.B. et al. Safety and efficacy of drug-eluting stents in women: a patientlevel pooled analysis of randomized trials. Lancet. 2013; 382 (9908): 1879–88.
  15. Johnson H.M., Gossett L.K., Piper M.E., Aeschlimann S.E., Korcarz C.E., Baker T.B. et al. Effects of smoking and smoking cessation on endothelial function: 1-year outcomes from a randomized clinical trial. J. Am. Coll. Cardiol. 2010; 55 (18): 1988–95.
  16. McManus D.D., Gore J., Yarzebski J., Spencer F., Lessard D., Goldberg R.J. et al. Recent trends in the incidence, treatment, and outcomes of patients with STEMI and NSTEMI. Am. J. Med. 2011; 124 (1): 40–7.
  17. Dzavík V., Buller C.E., Lamas G.A., Rankin J.M., Mancini G.B., Cantor W.J. et al. Randomized trial of percutaneous coronary intervention for subacute infarct-related coronary artery occlusion to achieve long-term patency and improve ventricular function: the Total Occlusion Study of Canada (TOSCA)-2 trial. Circulation. 2006; 114 (23): 2449–57.
  18. Thigesen K., Alpert J.S., Jaffe A.S., Simoons M.L., Chaitman B.R., White H.D. et al. Third universal definition of myocardial infarction. Eur. Heart J. 2012; 33 (20): 2551–67.
  19. Hammar N., Alfredsson L., Rosén M., Spetz C.L., Kahan T., Ysberg A.S. A national record linkage to study acute myocardial infarction incidence and case fatality in Sweden. Int. J. Epidemiol. 2001; 30 (Suppl. 1): S30–4.
  20. Eitel I., Desch S., de Waha S., Fuernau G., Gutberlet M., Schuler G., Thiele H. Sex differences in myocardial salvage and clinical outcome in patients with acute reperfused ST-elevation myocardial infarction: advances in cardiovascular imaging. Circ. Cardiovasc. Imaging. 2012; 5 (1): 119–26.
  21. Novack V., Cutlip D.E., Jotkowitz A., Lieberman N., Porath A. Reduction in sex-based mortality difference with implementation of new cardiology guidelines. Am. J. Med. 2008; 121 (7): 597–603.
  22. Koek H.L., de Bruin A., Gast F., Gevers E., Kardaun J.W., Reitsma J.B. et al. Short- and longterm prognosis after acute myocardial infarction in men versus women. Am. J. Cardiol. 2006; 98 (8): 993–9.
  23. Aldasoro E., Calvo M., Esnaola S., Hurtado de Saracho I., Alonso E., Audicana C. et al. Gender differences in early reperfusion treatment after myocardial infarction. Med. Clin. 2007; 128 (3): 81–5.

Chief Editor

Leo A. Bockeria, MD, PhD, DSc, Professor, Academician of Russian Academy of Sciences, President of Bakoulev National Medical Research Center for Cardiovascular Surgery